EFPIA and PhRMA release their own guideline for sharing clinical trial data

 July 25 2013 | By Márcio Barra

Following news of the leaked memo from the European Federation of Pharmaceutical Industries and Associations (EFPIA) earlier this week that sparked a wave of controversy, the EFPIA and the U.S.’ Pharmaceutical Research and Manufacturers of America (PhRMA) released their joint set of principles detailing their strategy to allow a more open access to clinical trial data.

View original post 281 more words

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s